2008
DOI: 10.1016/j.jep.2007.10.038
|View full text |Cite
|
Sign up to set email alerts
|

Animal models to test drugs with potential antidiabetic activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
170
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 244 publications
(175 citation statements)
references
References 107 publications
5
170
0
Order By: Relevance
“…b Triglycerides level before and after treatment. All the values were found to be significant with diabetic control at *P \ 0.05; **P \ 0.01; ***P \ 0.001 under the curve which is significantly lesser than the diabetic control group, and these findings are in accordance with previous research [36]. Figure 5 demonstrates the level of changes in body weight of experimental rats at before and after treatment.…”
Section: The Antidiabetic Activity Of Phytosynthesized Agnpssupporting
confidence: 89%
See 1 more Smart Citation
“…b Triglycerides level before and after treatment. All the values were found to be significant with diabetic control at *P \ 0.05; **P \ 0.01; ***P \ 0.001 under the curve which is significantly lesser than the diabetic control group, and these findings are in accordance with previous research [36]. Figure 5 demonstrates the level of changes in body weight of experimental rats at before and after treatment.…”
Section: The Antidiabetic Activity Of Phytosynthesized Agnpssupporting
confidence: 89%
“…Alloxan-induced diabetic rat model has been widely used in several studies [34,35]. In addition, the mode of action of alloxan is well documented [36]. In the treatment of diabetes, blood glucose concentration is considered as a routine and major biochemical marker to monitor the improvement in the disease condition, the results obtained for blood glucose concentration of treated groups showed a smaller total area Fig.…”
Section: The Antidiabetic Activity Of Phytosynthesized Agnpsmentioning
confidence: 99%
“…Streptozotocin, 2-deoxy-2-(3-(methyl-3-nitrosoureido)-D-glucopyranose, is by far the most frequently used agent (69%) in preparation of diabetic animal models for the study of multiple aspects of diabetes, and the dose required for inducing diabetes depends on the animal species, route of administration and nutritional status [9] . Consequently, in the present study a preliminary dose response effect of STZ on blood glucose (standardization) was carried out to determine the optimum dose needed to produce stable hyperglycemia in Sprague Dawley rats, as data in the literature could not be relied upon due to broad variability [10,11] .…”
Section: Discussionmentioning
confidence: 99%
“…Glibenclamide is a standard drug that is routinely used in the treatment of diabetes [15]. The extract's ability to significantly reduce hyperglycemia induced by alloxan may indicate a similar mechanism with glibenclamide which, being a sulphonylurea stimulates the release of insulin [16]. Alloxan destroys pancreatic β-cells and thus reduces or completely inhibit insulin secretion resulting in hyperglycemia [14].…”
Section: Discussionmentioning
confidence: 99%